Concepedia

Faith E. Nathan

FE

Statistics

Publications

38

Citations

9.2K

H-Index

28

Active since

1994

Affiliations

Bristol-Myers Squibb (United States)(Current)

Fox Chase Cancer Center

Princess Alexandra Hospital

Emory University

German Center for Lung Research

Faith E. Nathan is an author at Bristol-Myers Squibb (United States) specializing in medicine, oncology, and pharmacology.

Publications per year

1994–2023

38

Publications

38

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

Matthew D. Hellmann, Tudor–Eliade Ciuleanu, Adam Płużański et al. · New England Journal of Medicine · 2018 · 3.1K citations · Full text

, , +17

Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

Matthew D. Hellmann, Luis Paz‐Ares, Bogdan Żurawski et al. · New England Journal of Medicine · 2019 · 2.8K citations · Full text

, , +17

Nivolumab Monotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Scott Gettinger, Naiyer A. Rizvi, Laura Q.M. Chow et al. · Journal of Clinical Oncology · 2016 · 498 citations · Full text

, , +17

Nivolumab in Combination With Platinum‐Based Doublet Chemotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Naiyer A. Rizvi, Matthew D. Hellmann, Julie R. Brahmer et al. · Journal of Clinical Oncology · 2016 · 447 citations · Full text

, , +17

First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial

Luis Paz‐Ares, Suresh S. Ramalingam, Tudor–Eliade Ciuleanu et al. · Journal of Thoracic Oncology · 2021 · 322 citations · Full text

, , +17

1–5 of 38